Venrock Healthcare Capital Partners LP

Filings by Venrock Healthcare Capital Partners LP span 2 companies, the busiest being Chelsea Therapeutics International, Ltd. and Oruka Therapeutics, Inc. We count 5 filings; the first trade dates from 20 September 2010 and the latest from 27 February 2018.

On the open market, the record shows 1 purchase worth €271k and 4 sales worth €1.2M. Netting one side against the other leaves €895k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2018 alone, the filings show no purchases and 2 sales.

The latest filing, published on 28 February 2018, reports an open-market sale of €18k in Oruka Therapeutics, Inc. The most recent open-market purchase was published on 4 February 2011, 5,757 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.